Voltar
Artigo Revisado por pares
BIBTEX RIS

A phase I study of bortezomib in combination with doxorubicin and intermediate-dose dexamethasone (iPAD therapy) for relapsed or refractory multiple myeloma

2010; Springer Science+Business Media; Volume: 92; Issue: 3 Linguagem: Inglês

10.1007/s12185-010-0673-y

ISSN

1865-3774

Autores

Yasushi Takamatsu, Kazutaka Sunami, Hiroyuki Hata, Koji Nagafuji, Ilseung Choi, Masakazu Higuchi, Kimiharu Uozumi, Yasufumi Masaki, Kazuo Tamura,

Tópico(s)

Cancer Treatment and Pharmacology

Referência(s)